Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Crane

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Archives of Neurology|November 1, 1972
Pseudoparkinsonism and tardive dyskinesiaG E Crane
The American Journal of Psychiatry|December 1, 1971
Package inserts and tardive dyskinesiaG E Crane
The American Journal of Psychiatry|April 1, 1971
Persistence of neurological symptoms due to neuroleptic drugsG E Crane
The American Journal of Psychiatry|July 1, 1977
The prevention of tardive dyskinesiaG E Crane
Science (New York, N.Y.)|July 13, 1973
Clinical psychopharmacology in its 20th year. Late, unanticipated effects of neuroleptics may limit their use in psychiatryG E Crane
Diseases of the Nervous System|August 1, 1970
Cardiac toxicity and psychotropic drugsG E Crane
Archives of Neurology|February 1, 1970
High doses of trifluperazine and tardive dyskinesiaG E Crane
The New England Journal of Medicine|November 1, 1971
More on amantadine in tardive dyskinesiaG E Crane
The American Journal of Psychiatry|October 1, 1972
Prevention and management of tardive dyskinesiaG E Crane
The New England Journal of Medicine|January 11, 1973
Mediocre effects of reserpine on tardive dyskinesiaG E Crane
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Archives of Neurology|November 1, 1972
Pseudoparkinsonism and tardive dyskinesiaG E Crane
The American Journal of Psychiatry|December 1, 1971
Package inserts and tardive dyskinesiaG E Crane
The American Journal of Psychiatry|April 1, 1971
Persistence of neurological symptoms due to neuroleptic drugsG E Crane
The American Journal of Psychiatry|July 1, 1977
The prevention of tardive dyskinesiaG E Crane
Science (New York, N.Y.)|July 13, 1973
Clinical psychopharmacology in its 20th year. Late, unanticipated effects of neuroleptics may limit their use in psychiatryG E Crane
Diseases of the Nervous System|August 1, 1970
Cardiac toxicity and psychotropic drugsG E Crane
Archives of Neurology|February 1, 1970
High doses of trifluperazine and tardive dyskinesiaG E Crane
The New England Journal of Medicine|November 1, 1971
More on amantadine in tardive dyskinesiaG E Crane
The American Journal of Psychiatry|October 1, 1972
Prevention and management of tardive dyskinesiaG E Crane
The New England Journal of Medicine|January 11, 1973
Mediocre effects of reserpine on tardive dyskinesiaG E Crane
Pageof 3